For two decades, scientists believed intestinal cells transported bile acids in the same manner as liver cells – utilizing sodium-coupled or facilitative transporters for entry and ATP-binding cassette (ABC) transporters for export. That understanding has now been challenged with the discovery of a previously unknown transport mechanism, revealed through advanced analysis of existing data.
Researchers, re-examining mass spectrometry data, have identified polyamine-conjugated bile acids within intestinal cells. This finding, published recently, indicates a transport system distinct from the established model. The initial assumption, based on liver cell function, did not fully account for the complexities of the intestinal environment.
Bile acids are critical for nutrient absorption, mitochondrial function, and maintaining a healthy gut microbiome. They also play a role in regulating inflammation, appetite, and energy balance. The sheer number of bile acids – now known to include hundreds of modified forms, particularly amidated bile acids – suggests a far more intricate system than previously appreciated. There are currently over 2,400 known bile salt hydrolases, highlighting the extensive genetic and molecular resources dedicated to bile acid function throughout the human body.
This discovery comes as scientists increasingly recognize the diverse roles of bile acids beyond their traditional understanding of fat digestion. Research indicates they act as signaling molecules and influence immune responses. Disruptions in bile acid transport and homeostasis can lead to the accumulation of bile acids, contributing to cholestatic disorders and various liver diseases, including primary biliary cholangitis and primary sclerosing cholangitis.
The newly identified transport mechanism involves interactions between bile acids and cell membrane receptors, such as the Takeda G protein-coupled receptor 5 and the farnesoid X receptor. These interactions impact a range of physiological processes, from nutrient transport to maintaining the balance between pro- and anti-inflammatory states. Further investigation is focused on understanding how these interactions contribute to cholestatic liver injury, specifically the activation of hepatic stellate cells and hepatocyte apoptosis.
The implications of this finding extend to potential therapeutic strategies. Targeting bile acid pathways could offer new avenues for treating cholestatic liver diseases. However, the full extent of this newly discovered transport system and its impact on overall metabolic and immune homeostasis remains under investigation.
